Scrip
FDA approves Lilly's Zyprexa for use in adolescents
08 December 2009
Katie McQue
Please Login to read the full article.
08 December 2009
Katie McQue
katie.mcque@informa.com
The US FDA has extended the indication of Lilly's atypical antipsychotic Zyprexa (olanzapine) to include the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years.
The drug was first launched in the US in 1996 and is approved...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Seroquel collects more approvals, and a complete response letter, from the US FDA
- Alarming rise in chronic use of meds by American children, Medco report says
- Clinical trial violations delay US paediatric indication for Pfizer's Geodon
- US FDA approves Abilify for irritability in autistic children
COMMENT
Other Informa Comment
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
